Research Notes: Semler Scientific Looks Tempting After 48% Plunge
In this uneven market, big plunges can be buying opportunities. For SMLR, however, that doesn't appear to be the case.
SMLR has been halved in a week amid key changes surrounding insurance reimbursement.
There’s a case to buy the dip, given a fortress balance sheet and the possibility that the core QuantaFlo product provides enough value on its own.
History suggests stepping into these declines can be profitable. But it seems too difficult to jump into SMLR just y…